Research links variations in the gene GRIN2A to a higher risk of developing schizophrenia and other forms of mental illness.

A comprehensive new analysis is stirring debate in both psychiatry and public health: does owning a cat during childhood ...

Schizophrenia has long been framed as a disorder of broken thoughts and fractured perception, but a new line of research ...

A major scientific review reveals a deep knowledge gap in how cognition is affected when schizophrenia and personality disorders occur together.

People living with schizophrenia continue to battle not just their symptoms, delayed diagnoses and access to quality ...

Semaglutide medications like Ozempic and Wegovy can help lower the risk of heart and metabolic diseases in people with ...

A new study by a research team at Université de Montréal highlights a critical lack of knowledge about the cognitive profiles ...

New brain imaging research shows that structural damage in schizophrenia spectrum disorders may begin in specific “epicenter” regions before spreading across connected brain networks.

People with schizophrenia often take strong antipsychotics that control symptoms but frequently cause rapid weight gain, high blood sugar, and a ...

Schizophrenia spectrum disorders significantly increase cardiovascular and metabolic disease risks, partly due to antipsychotic-induced weight gain and glucose dysregulation.

GLP-1 drug could offset metabolic risks of second-generation antipsychotics ...